Wealth Shield Partners, LLC Chemo Centryx, Inc. Transaction History

Wealth Shield Partners, LLC

  • $721 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021
SELL
$9.59 - $50.88 $54,432 - $288,794
-5,676 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$49.53 - $68.4 $105,845 - $146,170
2,137 Added 60.38%
5,676 $291,000
Q4 2020

Feb 16, 2021
BUY
$47.25 - $65.16 $167,217 - $230,601
3,539 New
3,539 $219,000
Q3 2020

Oct 30, 2020
SELL
$46.35 - $61.69 $187,578 - $249,659
-4,047 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$38.58 - $65.07 $156,133 - $263,338
4,047 New
4,047 $233,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Wealth Shield Partners, LLC Portfolio

Follow Wealth Shield Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Shield Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Shield Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email